Researchers have developed a long-acting weekly injection that delivers steady doses of levodopa and carbidopa, potentially transforming care for Parkinson’s disease.

The reluctant decision by Morten Harket, lead singer in the legendary Norwegian band a-ha, to go public with his Parkinson’s ...

Scientists have been studying Parkinson’s for many years, but they still don’t fully understand why it happens. Without ...

Parkinson’s Disease is a progressive neurological disorder that will eventually lead to a late or end‑stage with severe ...

A progressive neurological disorder affecting 10 million people globally, Parkinson’s can cause disruptive symptoms such as ...

Researchers at Northwestern Medicine have discovered that a virus that has flown under the radar for years might be a ...

A team of neuroscientists in Australia has found that restoring copper levels in the brain dramatically reduced Parkinson-like damage in mice. The approach restored a protein’s function, and the same ...

A drug used for Parkinson’s has been shown to be effective in reducing the symptoms of difficult to treat depression, in a study led by ...

Parkinson's disease affects approximately 10 million people worldwide. It typically begins asymmetrically, initially ...

People with Parkinson’s often stay silent about their diagnosis. Here’s what drives that silence and why understanding it ...

Muscle stiffness, or rigidity, is another common early sign. It can happen in the arms, legs, or body and may feel like ...

Scientists have discovered that earwax may hold clues to early Parkinson's detection. Analyzing volatile organic compounds ...